Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [cHiC-seq]

ABSTRACT: Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [cHiC-seq]

PROVIDER: PRJNA521025 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8531040_1.fastq.gz	Fastqsanger.gz
	SRR8531040_2.fastq.gz	Fastqsanger.gz
	SRR8531041_1.fastq.gz	Fastqsanger.gz
	SRR8531041_2.fastq.gz	Fastqsanger.gz
	SRR8531042_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans

Project description:Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans

| PRJNA521021 | ENA

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [cHiC-seq]

Project description:Obesity and type 2 diabetes (T2D) are metabolic disorders influenced by lifestyle and genetic factors, and characterized by insulin resistance in skeletal muscle, a prominent site of glucose disposal. Numerous genetic variants have been associated with obesity and T2D, of which the majority is located in non-coding DNA regions. This suggest that most variants mediate their effect by altering the activity of gene-regulatory elements, including enhancers. Here, we map skeletal muscle genomic enhancer elements that are dynamically regulated after exposure to the free fatty acid palmitate or the inflammatory cytokine TNFα. By overlapping enhancer positions with the location of disease-associated genetic variants, and resolving long-range chromatin interactions between enhancers and gene promoters, we identify target genes involved in metabolic dysfunction in skeletal muscle. The majority of these genes also associate with altered whole-body metabolic phenotypes in the murine BXD genetic reference population. Thus, our combined genomic investigations identified genes that are involved in skeletal muscle metabolism and linked to SNPs associated with the development of obesity and T2D.

2020-03-26 | GSE126100 | GEO

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [ChIP-seq]

Project description:Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [ChIP-seq]

| PRJNA521022 | ENA

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [RNA-seq]

Project description:Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [RNA-seq]

| PRJNA521024 | ENA

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [RNA-seq]

2020-03-26 | GSE126101 | GEO

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans [ChIP-seq]

2020-03-26 | GSE126099 | GEO

Skeletal muscle enhancer interactions identify genes controlling whole body metabolism in humans

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-03-26 | GSE126102 | GEO

Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism.

Project description:Obesity and type 2 diabetes (T2D) are metabolic disorders influenced by lifestyle and genetic factors that are characterized by insulin resistance in skeletal muscle, a prominent site of glucose disposal. Numerous genetic variants have been associated with obesity and T2D, of which the majority are located in non-coding DNA regions. This suggests that most variants mediate their effect by altering the activity of gene-regulatory elements, including enhancers. Here, we map skeletal muscle genomic enhancer elements that are dynamically regulated after exposure to the free fatty acid palmitate or the inflammatory cytokine TNFα. By overlapping enhancer positions with the location of disease-associated genetic variants, and resolving long-range chromatin interactions between enhancers and gene promoters, we identify target genes involved in metabolic dysfunction in skeletal muscle. The majority of these genes also associate with altered whole-body metabolic phenotypes in the murine BXD genetic reference population. Thus, our combined genomic investigations identified genes that are involved in skeletal muscle metabolism.

| S-EPMC7264154 | biostudies-literature

Reverse gene-environment interaction approach to identify variants influencing body mass index in humans

Project description:Reverse gene-environment interaction approach to identify variants influencing body mass index in humans

| PRJNA531837 | ENA

Exploring roles of the chitinase ChiC in modulating Pseudomonas aeruginosa virulence phenotypes

Project description:Chitinases are ubiquitous enzymes involved in biomass degradation and chitin turnover in nature. Pseudomonas aeruginosa (PA), an opportunistic human pathogen, expresses ChiC, a secreted glycoside hydrolase 18 (GH18) family chitinase. Despite speculation about ChiC's role in PA disease pathogenesis, there is scant evidence supporting this hypothesis. Since PA cannot catabolize chitin, we investigated the potential function(s) of ChiC in PA pathophysiology

2024-04-30 | PXD048596 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data